Intern: Emerging Neuroscience Research Unit

  • Full-time
  • Region: US
  • Department: Interns & Co-ops

Job Description

This is for a 12-week internship position from June - August 2020.

The Emerging Neuroscience Research unit is responsible for validating novel drug targets and developing candidate molecules towards a wide range of disease indications. The current position will be embedded within a research team that focuses on the validation of early exploratory targets related to neuropsychiatric disorders and chronic pain.  The candidate will work on developing state-of-the art, imaging based-electrophysiology assays.  Novel cell lines will be produced through CRISPR gene editing of either immortalized or IPSC cell lines.

Position Description

The candidate will be expected to work in a highly collaborative team environment to support ongoing target validation studies.  The candidate will be expected to perform various experiments using cell biology techniques including:

  • Generation of cellular and tissue lysates
  • Protein quantification techniques (Western blot, ELISA)
  • Molecular biology (plasmid preparation and cloning)
  • Viral work (lentivirus and adenovirus)
  • Cell culture

Qualifications

To participate in the Biogen Co-op Program, students must meet the following eligibility criteria:

  • Legal authorization to work in the U.S.
  • Grade point average of 3.2 or higher preferred
  • At least 18 years of age prior to the scheduled start date
  • Be currently enrolled in an accredited college or university

The preferred candidate will have an academic background in basic biology including biochemistry and molecular biology. Experience in lab techniques is preferred.

Education
Major is biology, chemistry, or neuroscience

Location
Cambridge, MA

Relocation is not offered for this position.

Additional Information

All your information will be kept confidential according to EEO guidelines.

The Emerging Neuroscience Research unit is responsible for validating novel drug targets and developing candidate molecules towards a wide range of disease indications. The current position will be embedded within a research team that focuses on the validation of early exploratory targets related to neuropsychiatric disorders and chronic pain.  The candidate will work on developing state-of-the art, imaging based-electrophysiology assays.  Novel cell lines will be produced through CRISPR gene editing of either immortalized or IPSC cell lines.

Privacy Policy